Financial Gravity Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Financial Gravity Asset Management's NVS Position: Q1 2026 in Review
Financial Gravity Asset Management reduced its Novartis (NVS) stake by 0.96% in Q1 2026, selling an estimated $71.4K and leaving 47,971 shares worth $7.33M. The position accounts for 1.3% of the portfolio, ranked #21.
Financial Gravity Asset Management first reported a position in NVS in Q1 2018 and has held it in 15 quarters since. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Financial Gravity Asset Management held 47,971 shares of Novartis worth $7.33M as of Q1 2026.
- Financial Gravity Asset Management sold 466 Novartis shares in Q1 2026, an estimated $71.4K.
- Novartis made up 1.3% of Financial Gravity Asset Management's portfolio in Q1 2026, its #21 holding.
- Financial Gravity Asset Management first reported a position in Novartis in Q1 2018 and has held it in 15 quarters since.
- 1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.